M V, Gnk G, B B, Jagadeesan R, M R PK. Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration. amm [Internet]. 9Mar.2022 [cited 4May2024];68(1). Available from: https://ojs.actamedicamarisiensis.ro/index.php/amm/article/view/126